Carcinoma Ex Pleomorphic Adenoma of the Parotid Gland: A Rare Case.

Autor: Umar Z; Internal Medicine, Icahn School of Medicine at Mount Sinai, Queens Hospital Center, New York, USA., Ilyas U; Internal Medicine, Icahn School of Medicine at Mount Sinai, Queens Hospital Center, New York, USA., Alshamam MS; Internal Medicine, NYC Health + Hospitals, New York, USA.; Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, USA., Foster A; Internal Medicine, Icahn School of Medicine at Mount Sinai, Queens Hospital Center, New York, USA., Bhangal R; Internal Medicine, Icahn School of Medicine at Mount Sinai/NYC Health + Hospitals, New York, USA., Ahmed N; Internal Medicine, Queens Hospital Center, New York, USA., Idrees Z; Internal Medicine, Icahn School of Medicine at Mount Sinai/NYC Health + Hospitals, New York, USA.
Jazyk: angličtina
Zdroj: Cureus [Cureus] 2022 May 26; Vol. 14 (5), pp. e25357. Date of Electronic Publication: 2022 May 26 (Print Publication: 2022).
DOI: 10.7759/cureus.25357
Abstrakt: Cancer is a major cause of morbidity and mortality worldwide, with squamous cell carcinoma (SCC) being the most common type. Even though SCC is the major type of cancer found in the head and neck region, the salivary glands contribute to about 1/20 cases, of which 1/10 are said to be carcinoma ex pleomorphic adenoma (CXPA) type, and the parotid gland is found to be the most common origin of such cases. Although it usually arises later in life, it can grow rapidly, with local symptoms being late findings, if any. Even though fine needle aspiration cytology has low sensitivity for diagnosing such cancer, multiple/repeated biopsies can increase the yield and the accuracy of the test. Surgical resection is the main choice for treatment with postoperative radiation for select cases. Our case presented with CXPA with distant metastasis to multiple sites.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright © 2022, Umar et al.)
Databáze: MEDLINE
Externí odkaz: